Safety of oral Propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study)

American Journal of Cardiology

Volumn 81, Issue 9, 1998, Pages 1121-1124

  Janoušek, Jan ^a   Paul, Thomas ^b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ENCAINIDE; FLECAINIDE; PROPAFENONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG SAFETY; ELECTROCARDIOGRAPHY; GASTROINTESTINAL SYMPTOM; HEART ARREST; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA;

ADMINISTRATION, ORAL; ADOLESCENT; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; EUROPE; HEART ARREST; HUMANS; INFANT; INFANT, NEWBORN; PROPAFENONE; RETROSPECTIVE STUDIES;

EID: 0032076261     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00142-8     Document Type: Article

References (24)

1. Funck-Brentano C, Kroemer HK, Lee JT, Roden DM. Propafenone. N Engl J Med. 322:1990;518-524.
2. Dukes ID, Vaughan Williams EM. The multiple modes of action of propafenone. Eur Heart J. 5:1984;115-125.
3. Breithardt G, Borgrefe M, Wiebringhaus E, Seipel L. Effect of propafenone in the Wolff-Parkinson-White syndrome electrophysiologic findings and long-term follow-up . Am J Cardiol. 54:1984;29D-39D.
4. Shen EN, Sung RJ, Morady F, Schwartz AB, Scheinman MM, DiCarlo L, Shapiro W. Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia. J Am Coll Cardiol. 3:1984;1291-1297.
5. Coumel P, Leclerq JF, Assayag P. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. Am J Cardiol. 54:1984;60D-66D.
6. Ravid S, Podrid PJ, Novrit B. Safety of long-term propafenone therapy for cardiac arrhythmia - experience with 774 patients. J Electrophysiol. 1:1987;580-590.
7. Ludmer PL, McGowan NE, Antman EM, Friedman PL. Efficacy of propafenone in Wolff-Parkinson-White syndrome electrophysiologic findings and long-term follow-up . J Am Coll Cardiol. 9:1987;1357-1363.
8. Reimer A, Paul T, Kallfelz HC. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac arrhythmias. Am J Cardiol. 68:1991;741-744.
9. Guccione P, Drago F, Di Donato RM, Cicini MP, Pasquini L, Marino B, Marcelletti C, Ragonese P. Oral propafenone therapy for children with arrhythmias efficacy and adverse effects in mid-term follow-up . Am Heart J. 122:1991;1022-1027.
10. Janoušek J, Paul T, Reimer A, Kallfelz HC. Usefulness of propafenone for supraventricular arrhythmias in infants and children. Am J Cardiol. 72:1993;294-300.
11. Paul T, Reimer A, Janoušek J, Kallfelz HC. Efficacy and safety of propafenone in congenital junctional ectopic tachycardia. J Am Coll Cardiol. 20:1992;911-914.
12. Lucet V, Do Ngoc D, Fidelle J, Sidi D, Batisse A, Loth P, Vrancea F, Villain E, Coumel P. Efficacite anti-arrhythmique de la propafenone chez l'enfant. Arch Mal Coeur. 80:1987;1385-1393.
13. Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G, Weber H. Die Behandlung von Herzrhythmusstörungen mit Propafenon bei Säuglingen und Kindern. Monatsschr Kinderheilkd. 133:1985;154-157.
14. Weber H, Eigster G, Wesselhoeft H. Propafenon in der Behandlung von Herzrhythmusstörungen im Säuglings- und Kindesalter. Monatsschr Kinderheilkd. 129:1981;410-413.
15. Musto B, D'Onofrio A, Cavarallo C, Musto A. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Circulation. 78:1988;863-869.
16. Garson A, Moak JP, Smith RT, Norton JB. Usefulness of intravenous propafenone for control of postoperative junctional ectopic tachycardia. Am J Cardiol. 59:1987;1422-1424.
17. Paul T, Janoušek J. New antiarrhythmic drugs in pediatric use propafenone . Pediatr Cardiol. 15:1994;190-197.
18. Preliminary report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction . N Engl J Med. 321:1989;406-412.
19. Morganroth J, Anderson JL, Gentzkow CD. Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide. J Am Coll Cardiol. 8:1986;607-615.
20. Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction. Am J Cardiol. 62:1988;571-575.
21. Fish FA, Gillette PC, Benson DW, for the Pediatric Electrophysiology Group. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. J Am Coll Cardiol 1991;18:356-365.
22. Velebit V, Podrid P, Lown B, Cohen BH, Graboys TB. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation. 50:1982;886-894.
23. Perry JC, Garson A Jr. Encainide and flecainide in children separating the wheat from the chaff . J Am Coll Cardiol. 18:1991;366-367.
24. Deal BJ, Dick M, Beerman L, Silka M, Walsh E, Klitzner T, Kugler J. Cardiac arrest in young patients with Wolff-Parkinson-White syndrome (abstr). PACE. 18:1995;815.